YUMC Q1 2026 Earnings EPS Miss and Cautious Outlook Weigh on Shares Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Cineverse Q1 2026 Earnings SmallerThanExpected Loss as EPS Beats Estimates WABC Q1 2026 Earnings EPS Beats Estimates as Interest Income Stability Offsets Margin Pressures ASP Isotopes Q4 2025 Earnings PreRevenue Developer Reports WiderthanExpected Loss Yet Shares Rally 735 HCWC Q4 2025 Earnings Narrow Beat on EPS Provides Modest Relief Amid Stalled Revenue Disclosure